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Background: Outcome prediction in acute respiratory distress syndrome (ARDS) is challenging, especially 
in patients with severe hypoxemia. The aim of the current study was to determine the prognostic capacity of 
changes in PaO2/FiO2, dead space fraction (VD/VT) and respiratory system driving pressure (ΔPRS) induced 
by the first prone position (PP) session in patients with ARDS.
Methods: This was a post hoc analysis of the conveniently-sized ‘Molecular Diagnosis and Risk 
Stratification of Sepsis’ study (MARS). The current analysis included ARDS patients who were placed in the 
PP. The primary endpoint was the prognostic capacity of the PP-induced changes in PaO2/FiO2, VD/VT, and 
ΔPRS for 28-day mortality. PaO2/FiO2, VD/VT, and ΔPRS was calculated using variables obtained in the supine 
position before and after completion of the first PP session. Receiving operator characteristic curves (ROC) 
were constructed, and sensitivity, specificity positive and negative predictive value were calculated based on 
the best cutoffs.
Results: Ninety patients were included; 28-day mortality was 46%. PP-induced changes in PaO2/FiO2 and 
VD/VT were similar between survivors vs. non-survivors [+83 (+24 to +137) vs. +58 (+21 to +113) mmHg, and 
–0.06 (–0.17 to +0.05) vs. –0.08 (–0.16 to +0.08), respectively]. PP-induced changes in ΔPRS were different 
between survivors vs. non-survivors [–3 (–7 to 2) vs. 0 (–3 to +3) cmH2O; P=0.03]. The area under the ROC 
of PP-induced changes in ΔPRS for mortality, however, was low [0.63 (95% confidence interval (CI), 0.50 
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Introduction
One randomized clinical trial in patients with moderate 
to severe acute respiratory distress syndrome (ARDS) 
convincingly showed mortality benefit from turning 
patients from the supine to the prone position (PP) (1). Two 
meta-analyses confirmed the benefit of the PP (2,3), though 
the PP remains underutilized (4,5). Different mechanisms 
have been proposed to explain survival benefit induced 
by repositioning to the PP, including homogenizing of 
transpleural pressures, decreasing lung stress and strain by 
increasing lung volumes, and decreasing overdistension by 
redistribution of lung ventilation.
Outcome prediction in ARDS patients is challenging 
(6,7), especially in patients with severe refractory hypoxemia 
in whom PP sessions are often needed. In ARDS patients, 
the ratio of arterial oxygen partial pressure (PaO2) to 
fractional inspired oxygen (FiO2) ratio (PaO2/FiO2) (8), 
dead space fraction (VD/VT) (9,10), and respiratory system 
driving pressure (ΔPRS) (11,12) have an association with 
mortality. Turning a patient from supine to the PP affects 
PaO2/FiO2, VD/VT and ΔPRS through various mechanisms, 
and changes induced by this repositioning could be helpful 
in outcome prediction (6,7,13). A recent post hoc analysis 
of the randomized clinical trial (RCT) mentioned above (1) 
did not confirm this, though (14). It must be mentioned, 
however, that that analysis only used changes in PaO2/
FiO2 for outcome prediction, and also that changes were 
calculated from blood gas analysis results after positioning 
in the PP and before repositioning to the supine position.
The aim of the current analysis, therefore, was to 
determine the association between PP-induced changes in 
PaO2/FiO2, as well as VD/VT and ΔPRS, using ventilation 
variables collected before placing patients in the PP and 
after repositioning to supine, and outcomes. For this 
purpose, the ‘Molecular Diagnosis and Risk stratification 
of Sepsis’ study (MARS), a large cohort study including 
patients with ARDS needing PP, was reanalyzed. The 
primary hypothesis tested was that changes in PaO2/
FiO2, VD/VT and ΔPRS induced by the first PP session have 
prognostic capacity for mortality.
Methods
Design and ethical approval
MARS was a conveniently-sized observational study 
capturing granular data of intensive care unit (ICU) 
patients in two Dutch hospitals (15,16). In MARS, detailed 
demographic and clinical data, including ventilator settings 
and ventilation variables, as well as outcome data were 
prospectively collected from ICU admission and start of 
invasive ventilation, until extubation and ICU discharge, 
and 1-year mortality. The Institutional Review Board 
approved the study protocol of the parent study and the use 
of an opt-out consent procedure (protocol no. 10-056C). 
MARS was registered at www.clinicaltrials.gov (identifier 
NCT01905033). The current report adheres to the 
STROBE guidelines (17).
Patients
Patients were eligible for participation in MARS if they 
had an expected length of stay in the ICU of more than 
24 hours. MARS itself used no exclusion criteria.
For the purpose of this post hoc analysis, the following 
additional inclusion criteria were used: (I) admitted to 
the ICU of the Amsterdam University Medical Centers, 
location Academic Medical Center (AMC), Amsterdam, 
The Netherlands; (II) having ARDS; and (III) use of 
to 0.75]; PP-induced changes in ΔPRS had a sensitivity and specificity of 76% and 56%, and a positive and 
negative predictive value of 60% and 73%.
Conclusions: Changes in PaO2/FiO2, VD/VT, and ΔPRS induced by the first PP session have poor 
prognostic capacities for 28-day mortality in ARDS patients.
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the PP for refractory hypoxemia. The single reason for 
exclusion was impossibility to capture complete sets of 
variables, necessary for calculating PaO2/FiO2, VD/VT or 
ΔPRS before and after the first PP session. Thus, patients 
who died during the first PP session and patients who 
were transferred to another hospital while in the PP, were 
excluded.
ARDS diagnosis
The MARS team existed of extensively trained clinical 
researchers who scored all patients prospectively for 
presence of acute lung injury (ALI) or ARDS according to 
the American–European Consensus Conference criteria for 
ARDS (18). Patients were later re-classified using the Berlin 
Definition for ARDS that was introduced after initiation of 
the MARS (8). All patients initially diagnosed with ARDS 
also fulfilled the Berlin definition and could thus be re-
classified as having mild, moderate or severe ARDS based 
on the lowest PaO2/FiO2 within the first 24 hours after the 
initial diagnosis of ARDS (8).
Calculation of PaO2/FiO2, VD/VT and ΔPRS
PaO2 was measured using a point-of-care blood gas analyzer 
(Rapidlab 1265, Siemens Healthcare GmbH, Kemnath, 
Germany). Continuous end-tidal CO2 (EtCO2) monitoring 
was performed using main-stream capnography (Philips, 
Best, The Netherlands). FiO2, positive end-expiratory 
pressure (PEEP) and maximum airway pressure (Pmax) 
were recorded from the ventilator at the moment of blood 
sampling for blood gas analyses.
PaO2/FiO2, VD/VT, and ΔPRS were calculated using 
variables obtained in the supine position before and 
after completion of the first PP session. For these 
calculations, data 1 hour before start, and 1 hour after 
repositioning to the supine position were used. If these 
data were missing, we used data closest to the 1-hour 
time point but never more than 3 hours before start and 
3 hours after ending the first PP session. PaO2/FiO2 
was calculated by dividing PaO2 by FiO2. VD/VT was 
calculated using the modified Bohr formula in which 
VD/VT = (PaCO2–PetCO2)/PaCO2 (7). ΔPRS was calculated 
by subtracting PEEP from Pmax, measured at zero flow.
Primary and secondary endpoints
The primary endpoint was the prognostic capacity of 
PaO2/FiO2, VD/VT and ΔPRS, expressed in the area under 
the Receiver Operating Characteristic (ROC) for all–
cause mortality at day 28. Secondary outcomes were the 
prognostic capacities of PaO2/FiO2, VD/VT and ΔPRS for 
ICU and 1-year mortality. These outcomes should be seen 
as explorative, and therefore no correction for multiple 
testing was performed.
The local guideline for ventilatory support
The local guideline for ventilatory support advised on 
main ventilator settings in patients with ARDS, and 
indications for the PP (19). Briefly, ARDS patients were 
to receive invasive ventilation using a pressure-controlled 
ventilation mode, or pressure support ventilation mode, 
with tidal volume targeting 6 ml per kilogram of predicted 
body weight and PEEP following a ‘lower PEEP/FiO2 
table’, where every increase in PEEP was to be preceded 
by a recruitment maneuver. Nurses and physicians 
adjusted the inspiratory pressure to maintain the correct 
tidal volume. 
Patients were assessed at least three times daily to 
determine whether weaning could start, consisting of 
switches to a pressure support mode of ventilation, if not yet 
spontaneously breathing. If pressure support ventilation was 
accepted, the level of support was gradually decreased to a 
minimum of 5 cmH2O at least three times per day. Tracheal 
extubation was performed at the discretion of attending 
physicians, based on general extubation criteria (20).
The local guideline for prone positioning
The local guideline dictated that PP sessions were indicated 
in patients in whom the PaO2/FiO2 remained <125 mmHg 
despite increases in PEEP level ≥10 cmH2O at a minimum 
FiO2 ≥0.6. Sessions were repeated if PaO2/FiO2 remained 
or dropped to <125 mmHg at a PEEP of ≥10 cmH2O at 
a minimum FiO2 ≥0.6 when back in the supine position. 
Of note, the local guidelines for ventilation do not allow 
changes in PEEP, neither when a patient is in the PP nor 
before the results of blood gas analyses become available 
when a patient is returned to supine.
Power calculation
A formal power calculation was not performed, but instead 
this analysis used all patients who had received at least one 
PP session during the 3 years MARS enrolled patients.
5007Journal of Thoracic Disease, Vol 11, No 12 December 2019
© Journal of Thoracic Disease. All rights reserved. J Thorac Dis 2019;11(12):5004-5013 | http://dx.doi.org/10.21037/jtd.2019.12.38
Analysis plan
Variables and parameters were expressed as medians [25th to 
75th interquartile range (IQR) for continuous variables, or 
percentages for categorical variables. Continuous variables 
and parameters were analyzed using a Mann-Whitney 
U-test or a Welch two-ample t-test, and proportions were 
compared using a Fisher exact test.
First, absolute and relative changes between PaO2/FiO2, 
VD/VT and ΔPRS before to after the first PP session were 
calculated and compared between 28-day survivors and non-
survivors using the Mann-Whitney U-test. The association 
between PP-induced changes in PaO2/FiO2, VD/VT, and 
ΔPRS, and mortality was determined using a univariate 
and multivariable logistic regression. A propensity score 
was entered into the multivariate model as a covariate to 
correct for disease severity and other baseline factors that 
could have influenced patient outcome (21), using the 
following predefined baseline variables: disease severity [age, 
an age-corrected Acute Physiology and Chronic Health 
Evaluation (APACHE) IV score], and baseline PaO2/FiO2, 
VD/VT, ΔPRS, VT, and respiratory rate (RR). These variables 
were selected because they are all suggested to have an 
association with mortality. As there were 41 events of the 
outcome of interest, i.e., 28-day mortality, and the general 
rule of thumb is that 10 events of the outcome of interest 
are required for each variable entered in the model (22), 
the multivariable analysis using only 2 variables can be seen 
as sufficiently powered. An etiological model was chosen 
because of the restricted sample size.
Second, area under the ROC curve for 28-day mortality 
was calculated for PP-induced changes in PaO2/FiO2, VD/VT 
and ΔPRS. The optimal cutoff was determined using the 
Youden index (23), and sensitivity, specificity, and positive 
and negative predictive values were calculated. A priori, 
an area under the curve (AUC) of ≤0.6 was considered 
‘poor’, 0.6–0.7 ‘fair’, 0.7–0.8 ‘good’, 0.8–0.9 ‘very good’ 
and ≥0.9 ‘excellent’ (24).
Statistical analyses were performed using R and the 
R-studio interface (R version 3.0, www.r-project.org). A P 
value <0.05 was considered as statistically significant.
Results
Patients
Of 3,946 patients enrolled in MARS in the participating 
center, 642 (16%) patients were diagnosed with ARDS 
(Figure 1). Of these, 102 (16%) patients were repositioned 
in the PP for at least one session. After exclusion of patients 
with incomplete datasets, 90 patients remained in the 
analysis. Baseline demographics, ventilation variables, and 
ventilations parameters before and after the first PP session 
are presented in Tables 1,2. All cause 28-day mortality rate 
was 46%. Patients who died were sicker according to the 
APACHE IV scores. Patients who died had higher VD/VT 
at baseline, while baseline PaO2/FiO2 and ΔPRS were not 
different between survivors and non-survivors. Patients 
with ARDS in MARS study who did not meet the criteria 
for and thus were not placed in the PP had similar baseline 
characteristics but were less sick according to the median 
APACHE IV score (Table S1). Time between start of 
invasive ventilation and the first PP session, total duration 
of the first PP session, and the total number of PP sessions 
during the entire ICU stay were not different between 
survivors and non-survivors (Table S2). In 90% and 96% 
of cases, data to calculate the parameters of interest were 
available within the last hour before the first PP session, and 
the first hour after repositioning to supine, respectively.
PP-induced changes in PaO2/FiO2, VD/VT, and ΔPRS
The first PP session resulted in a rise in PaO2/FiO2 that 
persisted after the patient was repositioned back in the 
supine position in 90% of the cases, and a decrease in VD/
VT and ΔPRS in 66% and 56%, respectively (Figure 2 and 
Table 2).
Survivors versus non-survivors
PP-induced changes in PaO2/FiO2 and VD/VT were not 
49 survivors 41 non–survivors
3,856 excluded
• 3,304 not fulfilling Berlin Definition
• 540 not having received PP
• 12 incomplete datasets
3,946 MARS  
admissions in AMC
90 analyzable ARDS 
patients who received PP
Figure 1 Patient flowchart. AMC, Amsterdam University Medical 
Centers, location Academic Medical Center.
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different between survivors and non-survivors. PP-induced 
changes in ΔPRS, though, were different between survivors 
and non-survivors (Figure 2 and Table S3). In the univariate 
logistic regression, only the absolute PP-induced change 
in ΔPRS, and the absolute and relative change in arterial 
pH induced by the first PP session showed an association 
with 28-day mortality (Table S4). These associations did not 
sustain in the multivariate analysis when corrected for the 
propensity score.
After repositioning back in the supine position, 
differences were also noted in arterial pH between survivors 
and non-survivors (Table S3).
Prognostic value of PP-induced changes in PaO2/FiO2, VD/
VT and ΔPRS
Prognostic characteristics of absolute and relative 
changes in induced by the first PP session are shown in 
Table 3. Only the absolute PP-induced change in ΔPRS 
had prognostic capacity, all other PP-induced changes 
performed poorly. The prognostic capacity for ICU-
mortality and 1-year mortality of PP-induced changes 
were also poor (Table S5,S6).
Discussion
The findings of this post hoc analysis of MARS can best 
be summarized as follows: (I) PP-induced changes in 
PaO2/FiO2 and VD/VT are not different between survivors 
and non-survivors; (II) PP-induced changes in ΔPRS are 
different between survivors and non-survivors, but the 
association with outcome is not independent; and (III) 
prognostic capacity for mortality of PP-induced changes in 
oxygenation and lung mechanics is insufficient for use in 
Table 1 Baseline characteristics
Characteristics Survivors (N=49) Non-survivors (N=41) P
Gender, male, n [%] 31 [63] 29 [71] 0.15
Age, median [IQR], years 55 [44 to 65] 58 [50 to 66] 0.59
Weight, median [IQR], kg 80 [73 to 90] 75 [62 to 89] 0.16
PBW, median [IQR] 66 [63 to 72] 71 [56 to 80] 0.65
BMI, median [IQR] 26 [24 to 29] 24 [22 to 28] 0.05
APACHE IV, median [IQR] 61 [50 to 86] 91 [75 to 110] <0.001
Reasons for ICU admission,  n [%]
Surgical 13 [27] 12 [29] 0.77
Pneumonia 17 [35] 11 [27] 0.42
Sepsis 5 [10] 1 [2] 0.14
Cardiac arrest 1 [2] 4 [10] 0.11
Other 13 [27] 13 [32] 0.59
Causes of ARDS,  n [%]
Sepsis 9 [18] 10 [24] 0.48
Pneumonia 31 [63] 19 [46] 0.17
Trauma 6 [12] 6 [15] 0.74
Aspiration 1 [2] 5 [12] 0.05
Cardiac arrest 1 [2] 1 [2] 0.89
Transfusion 1 [2] 0 [0] 0.71
Baseline characteristics for all patients, survivors and non-survivors. Values are expressed in percentages (%) of total patients in the group 
or median with interquartile ranges [IQR], where applicable. kg, kilogram; PBW, predicted body weight; BMI, body mass index; APACHE, 
acute physiology and chronic health evaluation; ICU, intensive care unit; ARDS, acute respiratory distress syndrome.
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clinical practice.
This is the first study that investigated the prognostic 
capacities of PP-induced changes in oxygenation, dead space 
and respiratory system mechanics for outcome prediction 
in ARDS patients. One strength of this study is that trained 
researchers collected data used for the calculation of PaO2/
FiO2, VD/VT and ΔPRS. In addition, these researchers were 
also extensively trained in using the diagnostic criteria for 
ARDS. MARS ran in a tertiary hospital, recruiting a broad 
selection of ARDS patients, increasing its external validity. 
Also, different from a recent post hoc analysis of the 
PROSEVA trial (1), in the current analysis we prevented 
‘contamination’ of the early effects of repositioning a 
patient in the PP by using data from before the first PP 
session. We also focused on sustained effects of the first PP 
session, and therefore only used data after repositioning to 
supine. We consider this is a fairer interpretation of PP-
induced changes in gas exchange and lung mechanics.
Though the PP has many benefits, it is still uncertain 
how ventilation mechanics are exactly altered during 
repositioning patients from the supine position to the PP, 
and whether they remain altered after repositioning back 
to the supine position. Recruitment of lung tissue, changes 
in intra-abdominal pressures, and chest wall and lung 
compliances have not been studied well in ARDS patients 
in the PP, and the exact physiological mechanisms remained 
uncertain so far. Factors such as weight and pressure 
relocation, compliance changes, changes in chest wall 
shape, perfusion and ventilation redistribution have been 
thought to be contributing factors (25). Even though lung 
compliance is known to improve in general during a PP 
session, this does not always happen (25).
While PaO2/FiO2 is used for risk classification in the 
Berlin Definition, the results of this current study did not 
find a difference between survivors and non-survivors. This 
may not be too surprising as the study included patients 
with more severe ARDS, in which mortality is highest. 
However, there was also no association between PP-
induced changes in PaO2/FiO2 and outcome. This is in line 
with a previous study investigating the predictive value of 
PP-induced changes in PaO2/FiO2 (14,26). In that study, 
mortality rates were similar for ‘responders’ and ‘non-
responders’, based on changes in PaO2/FiO2.
In line with a previous investigation (27), VD/VT before 
the first PP session was lower in survivors compared to non-
survivors. Indeed, in that previous study it was shown that 
higher VD/VT is associated with worse outcome in ARDS 
patients.
Table 2 Ventilation variables and parameters
Variables and 
parameters
Before the first PP session After the first PP session
Survivors (N=49) Non-survivors (N=41) P Survivors (N=49) Non-survivors (N=41) P
VT, mL/kg PBW 6.5 [5.8 to 6.9] 6.2 [5.1 to 6.5] 0.18 6.4 [6.0 to 7.0] 6.5 [5.5 to 8.0] 0.97
PEEP, cmH2O 15 [10 to 16] 15 [11 to 16] 0.77 15 [12 to 16] 15 [14 to 18] 0.05
Pmax, cmH2O 32 [26 to 39] 35 [29 to 40] 0.22 31 [29 to 36] 36 [33 to 38] 0.04
FiO2, % 70 [60 to 80] 70 [60 to 89] 0.72 53 [44 to 62] 50 [40 to 60] 0.10
PaO2, mmHg 66 [59 to 80] 65 [60 to 77] 0.64 92 [72 to 122] 85 [69 to 110] 0.29
PaCO2, mmHg 50 [39 to 58] 47 [42 to 62] 0.52 44 [38 to 50] 47 [35 to 56] 0.77
HCO3
–, mmol/L 24 [21 to 27] 22 [19 to 26] 0.07 24 [21 to 28] 22 [18 to 26] 0.02
pH 7.32 [7.26 to 7.39] 7.25 [7.17 to 7.33] 0.02 7.39 [7.33 to 7.42] 7.31 [7.20 to 7.40] 0.01
PaO2/FiO2 99 [79 to 130] 101 [69 to 117] 0.60 188 [117 to 226] 166 [127 to 225] 0.99
VD/VT 0.27 [0.22 to 0.36] 0.43 [0.34 to 0.51] <0.001 0.25 [0.17 to 0.35] 0.32 [0.23 to 0.52] 0.01
ΔPRS, cmH2O 18 [14 to 24] 20 [15 to 24] 0.44 17 [12 to 21] 19 [16 to 24] 0.03
Variables and parameters before and after the first PP session. Data are expressed as median with IQR. VT, tidal volume; PBW, predicted 
body weight; PEEP, positive end-expiratory pressure; Pmax, maximum airway pressure; FiO2, fraction of inspired oxygen; PaO2, arterial 
oxygen tension; PaCO2, arterial carbon dioxide tension; HCO3
–, arterial bicarbonate; PaO2/FiO2, ratio of arterial oxygen tension to fraction 
of inspired oxygen; VD/VT, dead space fraction; ΔPRS, respiratory system driving pressure.
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Table 3 Prognostic capacities of changes induced by the first PP session
Parameters AUROC (95% CI) Best cutoff Sensitivity (95% CI) (%) Specificity (95% CI) (%) PPV (%) NPV (%)
Absolute change
PaO2/FiO2 0.55 (0.43 to 0.67) +68 mmHg 59 (42 to 74) 60 (45 to 74) 56 63
VD/VT 0.51 (0.39 to 0.63) –0.10 46 (31 to 63) 65 (50 to 78) 53 58
ΔPRS 0.63 (0.51 to 0.75) –3 cmH2O 76 (60 to 88) 56 (41 to 71) 60 73
Relative change
PaO2/FiO2 0.55 (0.43 to 0.67) +78% 63 (47 to 78) 54 (39 to 69) 54 63
VD/VT 0.51 (0.39 to 0.63) –46% 88 (74 to 96) 31 (19 to 46) 52 75
ΔPRS 0.62 (0.50 to 0.73) –14% 76 (60 to 88) 50 (35 to 65) 56 71
AUROC, area under the receiver operator characteristics curve; PPV, positive predictive value; NPV, negative predictive value; CI, 
confidence interval; PaO2/FiO2, ratio between arterial oxygen tension and fraction of inspired oxygen; VD/VT, dead space fraction; ΔPRS, 
respiratory system driving pressure.
Figure 2 PP-induced changes in PaO2/FiO2, VD/VT and ΔPRS. Dots represent individual PaO2/FiO2, VD/VT and ΔPRS calculated using data 
collected closest to start, and as early as possible after the first PP session. Horizontal lines are medians. PaO2/FiO2, ratio between arterial 




















































Several recent reports showed an association between 
ΔPRS and outcome of ARDS patients (11,12,28). The ΔPRS 
has even been suggested as one of the most important 
ventilation parameters predicting outcome (4,11,29,30). 
The results of this current study add to this understanding 
with the finding that PP-induced changes in ΔPRS were 
significantly different between survivors and non-survivors. 
Changes in ΔPRS induced by the first PP session, however, 
remain to have a disappointing low prognostic capacity. Of 
note, in all patients PP-induced changes in ΔPRS resulted 
from a change in Pplat. This can be explained by the fact that 
the local guidelines for ventilation do not allow changes in 
PEEP during PP.
In some patients PaO2/FiO2 could have improved beyond 
the value that triggered the decision to start a PP session. 
This explains why the PaO2/FiO2 in the last hour before 
the first PP session was higher than the PaO2/FiO2 that 
triggered the team to initiate the first PP session, in line 
with the local guideline for invasive ventilation. Indeed, 
in between these two-time points changes, and even 
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improvements in PaO2/FiO2 are likely to occur, e.g., due to 
PEEP titrations or recruitment maneuvers. This finding is 
in line with what was found in the latest randomized clinical 
trial of the PP (1).
There are several reasons why we had to reject the 
hypothesis, apart from the realistic possibility that changes 
in oxygenation and lung mechanics induced by the first PP 
session may not be associated with outcome. The sample 
size of this study was relatively small, and hereby possibly 
not able to detect the prognostic capacity. It is also possible 
that changes in PEEP during the first PP session affected 
the PP–induced changes in the parameters of interest. 
The findings of the present study may also be seen in light 
of finding of other studies in which ‘improvements’ in 
physiologic parameters did not translate in better outcomes, 
or vice versa. For instance, the seminal RCT comparing low 
vs. high tidal volumes showed ventilation with a low tidal 
volume to improve survival, but to worsen oxygenation (31). 
More recently, a randomized clinical trial of high PEEP and 
recruitment maneuvers showed the intervention to improve 
oxygenation and even driving pressure, but to worsen 
outcome (32). We cannot exclude a similar difference 
between changes in physiologic parameters and outcomes 
for positioning in the PP.
This study has several limitations. First, the results must 
be seen as those from a post hoc analysis. The relative low 
sample size could limit the generalizability of this analysis. 
However, the values included in the 95% CI of our primary 
endpoint (i.e., the AUROC) do not suggest a type II error. 
It was not possible to determine whether or not patients 
had received additional recruitment maneuvers during 
the first PP session, as this was not routinely captured 
in the database of MARS. Also, esophageal pressure 
measurements were not performed routinely, and therefore 
the pulmonary ΔP could not be calculated. Because 
patients were exclusively under pressure-controlled 
ventilation, Pmax instead of Pplat was used, as suggested 
previously (33-35). Furthermore, severity of illness scores 
like APACHE scores and SAPS have robust prognostic 
capacities, and thus should be held in consideration when 
investigating the prognostic capacities of the parameters 
of interest in this study. However, the multivariate analysis 
adjusted for a propensity score calculated from age, an 
age-corrected APACHE IV, and baseline PaO2/FiO2, VD/
VT, ΔPRS, VT, and the respiratory rate, also failed to find 
an association between changes in the parameters and 
outcomes. Finally, the study focused on the first PP session 
and not successive sessions.
Conclusions
In conclusion, in this cohort of ARDS patients the first PP 
session induced changes in PaO2/FiO2, VD/VT, and ΔPRS. 
Only changes in ΔPRS were different between survivors 
and non-survivors. Neither the change in PaO2/FiO2 and 
VD/VT, nor in ΔPRS induced by the first PP session had 
sufficient prognostic capacities for outcome.
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Supplementary
Table S1 Baseline characteristics of ARDS who did not meet the criteria for the PP
Characteristics Survivors (N=378) Non-survivors (N=162) P
Gender, male, n [%] 292 [65] 110 [68] 0.67
Age, median [IQR], years 61 [52 to 71] 63 [53 to 72] 0.43
Weight, median [IQR], kg 80 [70 to 90] 73 [65 to 87] 0.02
PBW, median [IQR] 65 [62 to 72] 72 [58 to 80] 0.06
BMI, median [IQR] 26 [23 to 29] 24 [22 to 28] 0.007
APACHE IV, median [IQR] 57 [49 to 84] 80 [63 to 109] <0.001
Reasons for ICU admission, n [%]
Surgical 126 [33] 37 [23] 0.01
Pneumonia 128 [34] 55 [34] 0.98
Sepsis 34 [9] 11 [7] 0.40
Cardiac arrest 11 [3] 12 [7] 0.02
Other 79 [21] 47 [29] 0.04
Causes of ARDS, n [%]
Sepsis 73 [19] 36 [22] 0.44
Pneumonia 236 [62] 83 [51] <0.001
Trauma 28 [7] 31 [19] 0.37
Aspiration 35 [9] 8 [5] 0.09
Cardiac arrest 5 [1] 4 [2] 0.34
Transfusion 1 [0] 0 [0] 0.27
Baseline characteristics for ARDS patients who did not receive the PP, survivors and non-survivors. Values are expressed in percentages (%) 
of total patients in the group or median with interquartile ranges [IQR], where applicable. kg, kilograms; PBW, predicted body weight; BMI, 
body mass index; APACHE, acute physiology and chronic health evaluation; ICU, intensive care unit; ARDS, acute respiratory distress 
syndrome.
Table S2 PP characteristics in survivors and non-survivors
Characteristics Survivors (N=49) Non-survivors (N=41) P
Time to first session, hours 15 [5 to 50] 12 [6 to 31] 0.46
Duration of first session, hours 8 [6 to 11] 9 [1 to 27] 0.28
Number of sessions 2 [1 to 2] 2 [1 to 2] 0.90
Characteristics of the PP sessions.
Table S3 Change in ventilation variables and parameters in survivors and non–survivors
Variables and parameters All Survivors (N=49) Non-survivors (N=41) P
VT, mL/kg PBW +0.3 [–0.3 to +1.2] +0.5 [–0.4 to +1.0] +0.4 [–0.9 to +1.4] 0.84
PEEP, cmH2O 0 [–1 to +3] 0 [–1 to +1] +1 [–1 to +5] 0.12
Pmax, cmH2O –1 [–5 to +6] –4 [–7 to +3] +1 [–2 to +7] 0.10
FiO2, % –20 [–30 to –5] –20 [–30 to –5] –15 [–30 to –5] 0.75
PaO2, mmHg +18 [+2 to +44] +22 [+3 to +47] +14 [+2 to +40] 0.61
PaCO2, mmHg –4 [–11 to +2] –4 [–11 to +1] –5 [–11 to +6] 0.76
HCO3
–, mmol/L –1 [–2 to +2] +1 [–2 to +3] –0.7 [–3.7 to +2.6] 0.66
pH +0.05 [–0.02 to +0.11] +0.08 [+0.03 to +0.11] +0.01 [–0.05 to +0.09] 0.02
PaO2/FiO2 +68 [+21 to +120] +83 [+24 to +137] +58 [+21 to +113] 0.30
VD/VT –0.07 [–0.16 to +0.06] –0.06 [–0.17 to +0.05] –0.08 [–0.16 to +0.08] 0.50
∆PRS, cmH2O –1 [–6 to +3] –3 [–7 to +2] 0 [–3 to +3] 0.03
Change in variables and parameters before and after the first PP session. Data are expressed as median with IQR. VT, tidal volume; PBW, 
predicted body weight; PEEP, positive end-expiratory pressure; Pmax, maximum airway pressure; FiO2, fraction of inspired oxygen; PaO2, 
arterial oxygen tension; PaCO2, arterial carbon dioxide tension; HCO3
–, arterial bicarbonate; PaO2/FiO2, ratio of arterial oxygen tension to 
fraction of inspired oxygen; VD/VT, dead space fraction; ∆PRS, respiratory system driving pressure.
Table S4 Univariate logistic regression
Variables and parameters Absolute change, OR [95% CI] P Relative change, OR [95% CI] P
VT, mL/kg PBW 1.00 [1.00 to 1.00] 0.85 1.01 [1.00 to 1.02] 0.37
PEEP, cmH2O 1.09 [0.98 to 1.21] 0.12 1.00 [1.00 to 1.00] 0.96
Pmax, cmH2O 1.06 [0.99 to 1.13] 0.10 1.01 [0.99 to 1.02] 0.42
FiO2, % 1.00 [0.97 to 1.02] 0.75 1.00 [0.98 to 1.01] 0.71
PaO2, mmHg 0.98 [0.91 to 1.05] 0.62 1.00 [0.99 to 1.00] 0.65
PaCO2, mmHg 1.04 [0.83 to 1.31] 0.74 1.01 [0.99 to 1.02] 0.51
HCO3
–, mmol/L 1.01 [0.96 to 1.07] 0.68 1.00 [0.98 to 1.01] 0.66
pH 0.00 [0.00 to 0.58] 0.03 0.69 [0.49 to 0.95] 0.03
PaO2/FiO2 1.00 [0.99 to 1.00] 0.30 1.00 [0.99 to 1.00] 0.31
VD/VT 0.47 [0.05 to 3.76] 0.48 1.00 [1.00 to 1.01] 0.30
∆PRS, cmH2O 1.06 [1.01 to 1.13] 0.03 1.08 [1.00 to 1.17] 0.09
Univariate logistic regression. Odds ratios are displayed for an increment of 1. OR, odds ratio; CI, confidence interval; VT, tidal volume; 
PBW, predicted body weight; PEEP, positive end-expiratory pressure; Pmax, maximum airway pressure; FiO2, fraction of inspired oxygen; 
PaO2, arterial oxygen tension; PaCO2, arterial carbon dioxide tension; HCO3
–, arterial bicarbonate; PaO2/FiO2, ratio of arterial oxygen 
tension to fraction of inspired oxygen; VD/VT, dead space fraction; ∆PRS, respiratory system driving pressure.
Table S5 Prognostic capacity of changes induced by the first PP session for ICU-mortality
Parameters AUROC (95% CI) Best cutoff Sensitivity (95% CI) (%) Specificity (95% CI) (%) PPV (%) NPV (%)
Absolute change
PaO2/FiO2 0.55 (0.43 to 0.67) +68 mmHg 56 (34 to 70) 58 (38 to 74) 51 63
VD/VT 0.51 (0.39 to 0.64) –0.10 46 (27 to 55) 64 (51 to 78) 50 60
ΔPRS 0.61 (0.50 to 0.73) –3 cmH2O 54 (33 to 72) 63 (47 to 79) 56 73
Relative change
PaO2/FiO2 0.54 (0.41 to 0.66) +190% 90 (71 to 99) 24 (11 to 36) 48 75
VD/VT 0.56 (0.44 to 0.68) –44% 85 (67 to 95) 32 (19 to 46) 49 73
ΔPRS 0.59 (0.47 to 0.71) –14% 74 (54 to 87) 48 (29 to 65) 53 71
AUROC, area under the receiver operator characteristics curve; PPV, positive predictive value; NPV, negative predictive value; CI, 
confidence interval; PaO2/FiO2, ratio between arterial oxygen tension and fraction of inspired oxygen; VD/VT, dead space fraction; ΔPRS, 
respiratory system driving pressure.
Table S6 Prognostic capacities of changes induced by the first PP session for 1-year mortality
Parameters AUROC (95% CI) Best cutoff Sensitivity (95% CI) (%) Specificity (95% CI) (%) PPV (%) NPV (%)
Absolute change
PaO2/FiO2 0.60 (0.45 to 0.75) +68 mmHg 67 (46 to 82) 68 (46 to 84) 64 70
VD/VT 0.54 (0.39 to 0.69) –0.11 70 (51 to 79) 48 (34 to 61) 54 65
∆PRS 0.66 (0.52 to 0.81) –3 cmH2O 63 (43 to 81) 77 (59 to 90) 71 71
Relative change
PaO2/FiO2 0.59 (0.44 to 0.74) +75% 63 (42 to 81) 65 (45 to 81) 61 67
VD/VT 0.54 (0.38 to 0.69) –28% 53 (36 to 73) 63 (47 to 71) 54 62
∆PRS 0.60 (0.48 to 0.73) –13% 55 (35 to 68) 71 (52 to 88) 61 66
AUROC, area under the receiver operator characteristics curve; PPV, positive predictive value; NPV, negative predictive value; CI, 
confidence interval; PaO2/FiO2, ratio between arterial oxygen tension and fraction of inspired oxygen; VD/VT, dead space fraction; ∆PRS, 
respiratory system driving pressure.
